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FEMALE Sprague Dawley rats given
7-12-dimethylbenzanthracene (DMBA) de-
velop mammary carcinomata, most of
which are hormone-dependent, regressing
following oophorectomy but regrowing
after oestrogen administration (Huggins,
1963). In these tumours, regression may
also be produced by administration of 5a-
reduced steroids (Huggins, Briziarelli and
Sutton, 1959; Huggins and Mainzer, 1957).
It is therefore of interest that DMBA-
induced rat mammary tumours have the
potential to synthesize 5a-reduced steroids
(King, Gordon and Helfenstein, 1964;
Miller, Forrest and Hamilton, 1974). The
aim ofthe present study was to determine
the effects of oestrogen on tumour 50c-
reduction oftestosterone.
Tumours were induced in randomly
bred female Sprague Dawley rats by
intravenous administration of5 mg DMBA
at 50 days of age. When the tumours
were approximately 2 x 2 cm in size the
rats were oophorectomized. Fourteen
days after oophorectomy the animals were
given daily subcutaneous injections of
oestradiol-17,8 in corn oil (1 jug or 5 ,ug).
This regime was continued for a further
14 days when the animals were sacrificed
by exsanguination. No injection was
given on the day of sacrifice. Tumour
size was monitored throughout the study
by measuring with calipers the two major
diameters at right angles, and expressing
the size of the resulting multiple in cm2.
Measurement was performed twice weekly
until oophorectomy and three times
weekly thereafter. Only tumours which
showed consistent regression after oopho-
rectomy and regrowth with oestrogen
treatment were classified as hormone-
dependent and taken for incubation.
All tumours were processed at 0°C until
incubation (within 30 min of tissue re-
moval). The tumours were finely sliced
and split into duplicate portions each
weighing 1 g. Krebs-Ringer phosphate
buffer pH 7-4 (10 ml), an NADPH-
generating system (200 pumol glucose-6-
phosphate, 30 ,umol NADP and 50 units
glucose-6-phosphate dehydrogenase) and
45 ICi 7ac-3H testosterone (sp. act. 12-4 Ci/
mmol from Radiochemical Centre, Amer-
sham) were added to each. One incubation
mixture was used without further addition
as a control; to the other was added
oestradiol-17,8 (1.5 ,ug/ml) to determine
the effects of oestrogen. Both systems
were then incubated by shaking at 37°C
in an atmosphere of oxygen for 1 h.
The reaction was stopped by adding
methanol (60 ml) and the incubations
were stored at -I0C until the steroids
were isolated and characterized.
Before extraction, 500 ,tg non-radio-
active carrier steroids (testosterone (17/?-
hydroxy-4-androsten-3-one), 5ac dihydro-
testosterone (17,8-hydroxy-5cc-androsten-
3-one) and 5x androstanediol (5cc-andro-
stane 3,8 17/3 diol)) were added to monitor
recovery losses. The metabolites were
extracted as described by Fahmy et al.HORMONE-DEPENDENT RAT MAMMARY CARCINOMATA
(1968) and separated into individual
steroids by continuous elution thin layer
chromatography for 2 h on Silica gel
HF254+366inchloroform: acetone (98: 2).
Purification of testosterone and 5x di-
hydrotestosterone involved sequential
acetylation and hydrolysis; that for 5oc
androstanediol sequential oxidation and
reduction (derivative formation and
chromatography systems as in Miller
et al., 1974). Although 5cx androstanediol
was added as the 3fl 17,/ isomer, the
methods described estimate total produc-
tion of all 4 isomers of 5ca androstanediol
since the isomers migrate together in the
initial chromatography system and the
subsequent oxidation step yields a com-
mon product, 5ac androstanedione. The
percentage metabolism of testosterone
and conversion to 5ac dihydrotestosterone
(DHT) and 5ac androstanediol were deter-
mined by measuring the percentage incor-
poration of radioactive label into the
appropriate metabolites after correction
for recovery losses. Total 5ac-reduction
was calculated by combining the per-
centage production of both 5ac DHT and
5ac androstanediol.
The results from these incubations are
presented in Table I. There was a wide
variation in metabolism of testosterone
between individual tumours. In vitro
addition of oestradiol produced variable
results on the level of testosterone metab-
olized, although the most common effect
was one of inhibition. Of the two 5a-
reduced metabolites of testosterone, the
production of 5ac androstanediol usually
exceeded that of 5ac DHT, in incubations
without added oestradiol. The in vitro
addition of oestradiol produced variable
effects on the production of 5c DHT,
although in tumours with the highest
control production of 5ac DHT, oestradiol
was consistently inhibitory. Oestradiol
inhibited the production of 50c andro-
stanediol in all carcinomata, with a
single exception, a tumour in which
oestradiol exclusively affected the produc-
tion of 5ac DHT. This meant that total
TABLE I.-In vitro Effects of Oestradiol on Steroid Metabolism by 10 Hormone-
dependent Rat Mammary Carcinomata
% Testosterone % 50 DHT % 5cx Androstanediol
Tumour metabolized produced produced °
* Control 16-85 5-85 9-60
Treated 25-25 4 50 0580
* Control 51-50 9-20 28 05
Treated 37 05 12-15 1-75
* Control 87 30 7-00 38-20
Treated 71-30 9-10 24 00
* Control 38 30 12-55 23 05
Treated 36-20 8-75 15-45
* Control 34 70 6-25 14 25
Treated 26 90 4-55 11-05
C Control 89-10 22-75 37-20
Treated 77-15 7-85 39-95
t Control 63 90 36-10 27 05
Treated 40 05 14-15 22-20
t Control 38-35 9-80 28-45
Treated 37-35 8-95 20 30
t Control 73-35 9.95 33-10
Treated 69-25 8 00 25 09
t Control 74-45 37 70 35-80
Treated 69-10 26-65 25 50
Control: Tumour incubated without oestradiol.
Treated: Tumour incubated in the presence of 1-5 ,sg/ml oestradiol.
Figures in parentheses represent percentage change produced by addition of oestradiol.
* Tumour regrowth following administration of oestradiol (1 ,ug/day).
t Tumour regrowth following administration of oestradiol (5 ,g/day).
O 5ac-reduction
15-45
5 30 (-66)
37-25
13-90 (-63)
45-20
33 - 10 25)
35-41
24-20 (-32)
20 50
15-60 (-24)
59.95
47-80 (-20)
63 -45
36*35 (-43)
38-25
29-25 (-24)
43 05
33 05 (-23)
73 50
52 15 (- 29)
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TABLE II.-In vitro Effects of Oestradiol on Steroid Metabolism by
Hormone-independent Rat Mammary Carcinomata
% Testosterone % 5n DHT %5ac Androstanediol
Tumour metabolized produced produced % 5cx-reduction
1.* Control 72-10 14-49 7-26 21-75
Treated 58 97 12-44 7 50 19-94 (-8)
2.t Control 89-27 42-72 22-17 64-89
Treated 92-35 4161 45-64 87-25 (+34)
Control: Tumour incubated without oestradiol.
Treated: Tumour incubated in the presence of 1-5 ,g/ml oestradiol.
Figures in parentheses represent percentage change produced by addition of oestradiol.
* Tumour growth continuous after both oophorectomy and administration of oestradiol (1 pg/day).
t Tumour growth continuous after oophorectomy but stimulated by administration of oestradiol
(1 dg/day).
5a-reduction was inhibited by oestradiol
in all tumours, the level of inhibition
varying between 20 and 65%.
Whilst in some tumours inhibition of
5a-reduction alone would account for the
effects of oestradiol on percentage metab-
olism of testosterone, in certain tumours,
oestradiol must have also affected other
steroid conversions. The production of
.\4 androstenedione and 5ac androstane-
dione was also investigated in several
tumours, but never exceeded 1% and did
not appear to be influenced by in vitro
addition of oestradiol.
These results indicate that oestradiol
17,8 may influence steroid metabolism by
rat mammary carcinomata. In vitro
addition of oestradiol reduces tumour
synthesis of 5ac-reduced metabolites from
testosterone, particularly 5ac androstane-
diol.
Although this is the first report that
oestrogen may affect the production of
5a-reduced steroids by mammary cancers,
it is well documented that 5ac-reduction
may be hormonally controlled in other
tissues such as liver (Schriefers, 1967),
adrenal cortex (Kitay, Coyne and Swygert,
1970) and prostate (Farnsworth, 1972).
In common with the results presented in
this study for mammary tissue, oestradiol
inhibits 5ac-reduction in both adrenal
cortex and prostate.
The synthesis of 5ac-reduced steroids
assumes added importance in mammary
tumours because both 5ac DHT and 5ac
androstanediol inhibit the growth of the
hormone-dependent rat mammary tumour
(Huggins et al., 1959; Huggins and
Mainzer, 1957). These effects ofoestradiol
in decreasing tumour synthesis of 5a-
reduced steroids would therefore be in
keeping with oestradiol's growth-
promoting effects in hormone-dependent
tumours. In this context it is interesting
that the same concentration of oestradiol
failed to inhibit 5ac-reduction in two
hormone-independent rat mammary car-
cinomata (Table II). Further numbers are
required before it will be possible to
determine if this represents a distinction
betweenhormone-dependentandhormone-
independent tumours.
Although the level of oestradiol added
in vitro (1.5 ,ug/ml) is high compared with
normal plasma levels in female rats
(0-1-4.4 ng/100 ml, Hawkins et al., 1975),
the dose used in this study is comparable
with that which in vitro inhibits 5ac-
reduction of testosterone in prostatic
tissue (Griffiths et al., 1970; Jenkins and
McCafferty, 1974) and that used in
predicting oestrogen sensitivity in human
breast tumours (Salih, Flax and Hobbs,
1972).
It remains to be seen, however, if
oestradiol in vivo has similar effects on
tumour steroidogenesis. Although
oophorectomy increases the level of 5ac-
reduction in rat mammary carcinomata,
an effect which can be reversed by
administration of oestrogen (Miller et al.,
1974), this could be caused by changes in
circulating oestrogen or prolactin.
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